We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Technique Reveals Earliest Signs of Genetic Mutations

By LabMedica International staff writers
Posted on 14 Jun 2024

Mutations are alterations in the molecular "letters" that constitute the DNA code, which serves as the blueprint for all living cells. More...

While some of these changes may be inconsequential, others can lead to serious diseases, including cancer. Now, a new study has introduced a groundbreaking technique that can accurately identify early molecular changes in the DNA code that precede mutations. This new method could enhance our understanding of the fundamental causes of mutations in both healthy and cancerous cells, as well as how genetic changes accumulate naturally in human cells as individuals age.

The technique, known as HiDEF-seq (Hairpin Duplex Enhanced Fidelity Sequencing), was developed by researchers at NYU Langone Health (New York, NY, USA), along with collaborators across North America and in Denmark. It focuses on resolving the initial stages of mutation occurring in DNA. DNA consists of two strands, each made up of molecular letters or bases: adenine (A), thymine (T), guanine (G), and cytosine (C). The bases on one strand pair specifically with those on the other, with A pairing with T and G pairing with C, which ensures the DNA code is replicated accurately and transmitted from one cell generation to the next. Notably, mutations are alterations that appear in the DNA on both strands; for example, a G-C base pair might mutate into an A-T base pair.

However, the researchers point out that most mutations originate from changes that occur in just one of the DNA strands, such as a mismatched G-T base pair. These single-strand changes, which previous testing methods could not precisely identify, may happen when a DNA strand is incorrectly copied during cell division or when a strand is damaged by heat or chemicals in the body. If these single-strand DNA changes are not repaired by the cell, they can become fixed and evolve into permanent double-strand mutations. The HiDEF-seq technique has demonstrated exceptional accuracy in detecting double-strand mutations, with an estimated error rate of only one in every 100 trillion base pairs analyzed. Importantly, HiDEF-seq can detect changes in the DNA code while they are still present on only one of the DNA strands before they change into permanent double-strand mutations.

"Our new HiDEF-seq sequencing technique allows us to see the earliest fingerprints of molecular changes in DNA when the changes are only in single strands of DNA," said senior study author Gilad Evrony, MD, PhD, a core member of the Center for Human Genetics & Genomics at NYU Grossman School of Medicine. "Our study lays the foundation for using the HiDEF-seq technique in future experiments to transform our understanding of how DNA damage and mutations arise. Our long-term goal is to use HiDEF-seq to create a comprehensive catalogue of single-strand DNA mismatch and damage patterns that will help explain the known double-strand mutation patterns. In the future, we hope to combine profiling of single-strand DNA lesions, as obtained from HiDEF-seq, with the lesions' resulting double-strand mutations to better understand and monitor the everyday effects on DNA from environmental exposures." The study was published in Nature on June 12, 2024.

Related Links:
NYU Grossman School of Medicine


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Rapid Test Reader
DIA5000
New
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The cell-based tests bring artificial intelligence to transplant outcome care (Photo courtesy of iStock)

AI-Enhanced Cell-Based Blood Tests to Improve Predictive Accuracy for Complex Transplant Outcomes

Managing immunosuppressive drugs in transplant patients is a delicate challenge. Insufficient medication can lead to rejection, which may be cell- or antibody-mediated, while excess immunosuppression raises... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Industry

view channel
Image: Alzheimer’s Association has released its first clinical practice guideline for blood-based biomarker tests (Photo courtesy of Alzheimer’s Association)

New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis

Alzheimer’s disease is a progressive neurodegenerative condition that remains challenging to diagnose early and accurately, particularly in individuals with cognitive impairment. Despite the availability... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.